Jump to main content

yr 〜
yr

Search results 3

Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992

Granting additional market exclusivity to the drug Ansaid : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992
Microform図書
1992<YCA-Y 4.En 2/3:102-99>
National Diet Library
  • Subject HeadingUpjohn Company Flurbiprofen -- Law and legislation -- United States Pharmaceutical policy -- Unit...

Private patent extensions : report (to accompany S. 526, S. 1165, and S. 1506) (Report)

Private patent extensions : report (to accompany S. 526, S. 1165, and S. 1506) (Report)
Microform図書
1992<YCA-Y 1.1/5:102-414>
National Diet Library
  • Subject Heading... United States Flurbiprofen -- Law and legislation -- United States Patent extensions -- United S...

Patent extension hearing : hearing before the Subcommittee on Patents, Copyrights, and Trademarks of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on S. 526 ... S. 1165 ... and S. 1506 ... August 1, 1991 (S. hrg. ; 102-824)

Patent extension hearing : hearing before the Subcommittee on Patents, Copyrights, and Trademarks of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on S. 526 ... S. 1165 ... and S. 1506 ... August 1, 1991 (S. hrg. ; 102-824)
Microform図書
1992<YCA-Y 4.J 89/2:S.HRG.102-824>
National Diet Library
  • Subject Heading... United States Flurbiprofen -- Law and legislation -- United States Sucrose polyester -- Law and ...

Reached to the end of result.

RSS